U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

Vietnam’s amended Law on Pharmacy, set to take effect on July 1, 2025, introduces key reforms to modernize the pharmaceutical ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.

In a relatively short time, RFK Jr. has forced America to begin to recognize that the food choices they make have significant ...

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 21.9% year on year to $17.76 billion. On the other hand, the company ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

particularly the Pharmaceutical industry with the PLI scheme. They've done quite a lot in recent years and can do more for Contract Research (CDMO business . By tradition, it's been more focused ...